CytoDyn Highlights CLOVER Progress, Early ctDNA Declines in Colorectal Cancer
https://finance.yahoo.com/healthcare/articles...06811.html
CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026
https://finance.yahoo.com/healthcare/articles...00706.html
CytoDyn to Host Investor Webcast
https://finance.yahoo.com/healthcare/articles...00409.html
CytoDyn Highlights Early CLOVER Data, Names Robert Hoffman CEO
https://finance.yahoo.com/healthcare/articles...14245.html
CytoDyn and QLHC Advance Leronlimab into Two New PRE-I-SPY Studies in Metastatic Triple-Negative Breast Cancer
https://finance.yahoo.com/healthcare/articles...00093.html
CytoDyn Announces $5 Million Private Investment to Advance Leronlimab in Colorectal Cancer and Other Solid Tumors
https://finance.yahoo.com/healthcare/articles...00042.html
CytoDyn Appoints Lauren Wilcoxen, Ph.D., as Chief Operating Officer and Head of Regulatory Affairs
https://finance.yahoo.com/healthcare/articles...00531.html
And, of course, today's webinar!